Evidence map›Paper›PMID 31844425›Full record

ArticleOpen access Macedonian journal of medical sciences2019

Antiarthritic Activity of

Velmurugan Chinnasamy, Vetriselvan Subramaniyan, Sarath Chandiran, Saminathan Kayarohanam, Dhanapal Chidambaram Kanniyan, Venkata Sathya Saiappala Raju Velaga, Shafiulla Muhammad

Open access · diamondAbstract read
In one paragraph

Article in Open access Macedonian journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Effects and molecular mechanisms ofFrontiers in pharmacology · 2025
    Review
  6. Review
  7. UnderstandingToxicology reports · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Developmental Toxicity of Ethanolic Extracts of Leaves ofJournal of experimental pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Velmurugan ChinnasamyDepartment of Chemistry, Toxicology Unit, College of Natural Sciences, Arba Minch University, Ethiopia.
Vetriselvan SubramaniyanDepartment of Pharmacology, Faculty of Medicine, MAHSA University, Malaysia.
Sarath ChandiranSchool of Pharmacy, Sri Balaji Vidyapeeth Deemed University, India.
Saminathan KayarohanamFaculty of Bio-economy and Health Sciences, Geomatika University College Kuala Lumpur, Malaysia.
Dhanapal Chidambaram KanniyanDepartment of Pharmacy, Annamalai University, India.
Venkata Sathya Saiappala Raju VelagaFaculty of Pharmacy, MAHSA University, Malaysia.
Shafiulla MuhammadDepartment of Pharmacology, Sri Krishna Chaithanya College of pharmacy, Madanapalle, Andhra Pradesh, India.
Mahsa University · MYAnnamalai University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the ameliorative potential of aqueous extract of Achyranthesaspera(AEAA) against arthritis using swiss albino mice and Wistar rats, and its possible mechanism of action.

methodsSwiss albino mice (25-30 g) and Wistar rats (150-180 g) under standard controlled conditions (24 ± 2°C, 50-70 humidity and 12 h light/dark cycle). The groups were divided into 6 groups (n = 6/group) and assigned as control, negative control, standard and, formaldehyde supplemented with two different test dose groups of A. aspera for 4 weeks. Arthritis induced by subplantar administration of 0.1 ml formaldehyde (2% v/v) into the left hind paw in all groups except normal control. Arthritis was assessed using serum Hb, ESR, paw volume, joint diameter, radiological and histopathological investigation.

resultsOral administration of AEAA shown a significant (p < 0.01) dose-dependent protection against formaldehyde induced arthritis. At 21st day, A.asperashown an inhibition of paw volume in the different doses of 250 mg/kg and 500 mg/kg were found to be 30% and, 38.33% respectively. At 14th day the joint swelling was found to be 27.2% and 36.36 respectively. Diclofenac (10 mg/kg) had an effect of 36.61% inhibition of arthritis and joint swelling at 21st and 14th day.

conclusionThus, the present study revealed that the aqueous extract of A. aspera offered significant protection against arthritis and joint inflammation.

Indexed as

AchyranthesasperaAnti-arthritisArthritisFormaldehyde

Identifiers

PMID31844425
PMCPMC6901860
OpenAlexW2981174826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.